Nonimmune hydrops fetalis: modern principles of diagnosis and treatment
- Authors: Kadyrberdieva F.Z1, Shmakov R.G1, Bokeria E.L1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 10 (2019)
- Pages: 28-35
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248626
- DOI: https://doi.org/10.18565/aig.2019.10.28-34
- ID: 248626
Cite item
Abstract
Full Text
About the authors
F. Z Kadyrberdieva
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: f_kadyrberdieva@oparina4.ru
postgraduate student Moscow 117997, Ac. Oparina str. 4, Russia
R. G Shmakov
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: r_shmakov@oparina4.ru
MD, professor of the Russian Academy of Sciences Moscow 117997, Ac. Oparina str. 4, Russia
E. L Bokeria
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: e_bokeriya@oparina4.ru
MD, professor, head of the department of pathology of newborn and premature babies Moscow 117997, Ac. Oparina str. 4, Russia
References
- Norton M.E., Chauhan S.P., Dashe J.S. Society for Maternal-Fetal Medicine (SMFM) clinical guideline No.7: nonimmune hydrops fetalis. Am. J. Obstet. Gynecol. 2015; 212(2): 127-39. doi: 10.1016 / j.ajog.2014.12.018
- Ota S., Sahara J., Mabuchi A., Yamamoto R., Ishii K., Mitsuda N. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis. J. Obstet. Gynaecol. Res. 2015; 42(4): 385-91. doi: 10.1055 / s-0037-1603890
- Hartge D.R., Weichert J., Gembicki M., Krapp M. Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 195: 128-32. doi: 10.1016/ j.ejogrb.2015.09.006
- Brock W.W., Bradshaw W.T. Congenital chylothorax. Adv. Neonatal Care. 2016; 16(2): 114-23. DOI: 10,1097 / ANC.0000000000000257
- Badantyne J.W. The Diseases and deformities of the fetus. Edinburgh: Oliver & Boyd; 1892.
- Ng Z.M., Seet M.J., Erng M.N., Buendia F., Chang A.S., Sriram B. Nonimmune hydrops fetalis in a childrens hospital: a six-year series. Singapore Med. J. 2013; 54(9): 487-90.
- Fukushima K, Morokuma S., Fujita Y., Tsukimori K., Satoh S., Ochiai M. et al. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum. Dev. 2011; 87(8): 571-5. doi: 10.1016/j.earlhumdev. 2011.04.015
- Milunsky A. Genetic disorders of the fetus: diagnosis, prevention and treatment. 5th ed. Baltimore: John Hopkins University Press, 2004.
- Bellini C., Donarini G, Paladini D., Calevo M.G., Bellini T., Ramenghi L.A., Hennekam R.C. Etiology of non-immune hydrops fetalis: an update. Am. J. Med. Genet. A. 2015; 167(5): 1082-8. doi: 10.1002 / ajmg.a.36988.
- Laterre M, Bernard P, Vikkula M., Sznajer Y. Improved diagnosis in nonimmune hydrops fetalis using a standardized algorithm. Prenat. Diagn. 2018; 38(5): 337-43. doi: 10.1002 / pd.5243
- Suwanrath-Kengpol C, Koranantakul O., Suntharasajet T., Leetanapon R. Etiology and outcome of non-immune hydrops fetalis in southern Thailand. Gynecol. Obstet. Invest. 2005; 59(3): 134-7. DOI: 10,1159 / 000082997
- Ratanasiri T., Komwilaisak R., Sittivech A., Kleebkeawet P., Seejorn K. Incidence, causes and pregnancy outcomes of hydrops fetalis at Srinagarind Hospital, 19962005: a 10-year review. J. Med. Assoc. Thai. 2009; 92(5): 594-9. doi:10.1111/ jog.12922
- Yang Y.H., Teng R.J., Tang J.R., Yau K.I., Huang L.H., Hsieh F.J. Etiology and outcome of hydrops fetalis. J. Formos. Med. Assoc. 1998; 97(1): 16-20. PMID: 9481059
- Ismail K.M., Martin W.L., Ghosh S., Whittle M.J., Kilby M.D. Etiology and outcome of hydrops fetalis. J. Matern. Fetal Med. 2001; 10(3): 175-81.
- Heinonen S., Ryynanen M., Kirkinen P. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet. Gynecol. Scand. 2000; 79(1): 15-8. PMID: 10646810
- Liao C., Wei J., Li Q., Li J., Li L., Li D. Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China. Fetal Diagn. Ther. 2007; 22(4): 302-5. DOI: 10,1159 / 000100796
- Anandakumar C., Biswas A., Wong Y.C., Chia D., Annapoorna V.,Arulkumaran S., Ratnam S. Management of non-immune hydrops: 8 years’ experience. Ultrasound Obstet. Gynecol. 1996; 8(3): 196-200. DOI: 10,1046 / j.1469-0705.1996.08030196.x
- Desilets V., De Bie I., Audibert F. No. 363-investigation and management of nonimmune fetal hydrops. J. Obstet. Gynaecol. Can. 2018; 40(8): 1077-90. doi: 10.1016 / j.jogc.2017.12.011.
- Lindenburg I.T., van Kamp I.L., Oepkes D. Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn. Ther. 2014; 36(4): 263-71. doi: 10.1159 / 000362812
- Sudrie-Arnaud B., Marguet F., Patrier S., Martinovic J., Louillet F., Broux F. et al. Metabolic causes of nonimmune hydrops fetalis: A next-generation sequencing panel as a first-line investigation. Clin. Chim. Acta. 2018; 481: 1-8. doi: 10.1016 / j.cca.2018.02.023
- Im S.S., Rizos N., Joutsi P., Shime J., Benzie R.J. Nonimmunologic hydrops fetalis. Am. J. Obstet. Gynecol. 1984; 148(5): 566-9. DOI: 10.1016 / 0002-9378 (84) 90749-х
- Chon A.H., Chmait H.R., Korst L.M., Llanes A., Ouzounian J.G., Chmait R.H. Long-term outcomes after thoracoamniotic shunt for pleural effusions with secondary hydrops. J. Surg. Res. 2019; 233: 304-9. doi: 10.1016 / j.jss.2018.08.022.
- Nakayama H., Kukita J., Hikino S., Nakano H., Hara T. Long-term outcome of 51 liveborn neonates with non-immune hydrops fetalis. Acta Paediatr. 1999; 88: 24-8. DOI: 10,1080 / 08035259950170547
- Smoleniec J., James D. Predictive value of pleural effusions in fetal hydrops. Fetal Diagn. Ther. 1995; 10: 95-100. DOI: 10,1159 / 000264213
- Liu C.A., Huang H.C., Chou Y.Y. Retrospective analysis of 17 liveborn neonates with hydrops fetalis. Chang Gung Med. J. 2002; 25(12): 826-31. PMID: 12635839
- Dorsi M., Giuseppi A., Lesage F., Stirnemann J., De Saint Blanquat L., Nicloux M. et al. Prenatal factors associated with neonatal survival of infants with congenital chylothorax. J. Perinatol. 2018; 38(1): 31-4. https://doi.org/10.1002/ uog.2733
- Wilson R.D., Baxter J.K., Johnson M.P., King M., Kasperski S., Crombleholme T.M. et al. Thoracoamniotic shunts: fetal treatment of pleural effusions and congenital cystic adenomatoid malformations. Fetal Diagn. Ther. 2004; 19(5): 413-20. DOI: 10,1159 / 000078994
- Schrey S., Kelly E.N., Langer J.C., Davies G.A., Windrim R., Seaward P.G., Ryan G. Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung. Ultrasound Obstet. Gynecol. 2012; 39(5): 515-20. doi: 10.1002 / uog.11084
- Yinon Y., Grisaru-Granovsky S., Chaddha V., Windrim R., Seaward P.G., Kelly E.N. et al. Perinatal outcome following fetal chest shunt insertion for pleural effusion. Ultrasound Obstet. Gynecol. 2010; 36(1): 58-64. doi: 10.1002 / uog.7507
- Simpson L.L.; Society for Maternal-Fetal Medicine. Twin-twin transfusion syndrome. Am. J. Obstet. Gynecol. 2013; 208(1): 3-18. DOI: https:// doi.org/10.1016/j.ajog.2012.10.880
- Lee H., Bebbington M., Crombleholme T.M. The North American Fetal Therapy Network Registry data on outcomes of radiofrequency ablation for twin-reversed arterial perfusion sequence. Fetal Diagn. Ther. 2013; 33(4): 224-9. doi: 10.1159 / 000343223.
- Abbasi N., Ryan G. Fetal primary pleural effusions: prenatal diagnosis and management. Best Pract. Res. Clin. Obstet. Gynecol. 2019; 58: 66-77. https:// doi.org/10.1016/ j.bpobgyn.2019.01.005.
- Shenker L. Fetal cardiac arrhythmias. Obstet. Gynecol.Surv. 1979; 34: 561-72. PMID: 384305
- Kleinman C.S., Nehgme R.A. Cardiac arrhythmias in the human fetus. Pediatr. Cardiol. 2004; 25(3): 234-51. DOI: 10,1007 / s00246-003-0589-x
- Jaeggi E., Ohman A. Fetal and neonatal arrhythmias. Clin. Perinatol. 2016; 43(1): 99-112. doi: 10.1016 / j.clp.2015.11.007
- Sridharan S., Sullivan I., Tomek V., Wolfenden J., Skovranek J., Yates R., et al. Flecainide versus digoxin for fetal supraventricular tachycardia: comparison of two drug treatment protocols. Heart Rhythm. 2016; 13(9): 1913-9. doi: 10.1016 / j.hrthm.2016.03.023.
- Krapp M., Kohl T., Simpson J.M., Sharland G.K., Katalinic A., Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003; 89(8): 913-7. DOI: 10.1136 / heart.89.8.913
- van Engelen A.D., Weijtens O., Brenner J.I., Kleinman C.S., Copel J.A., Stoutenbeek P., Meijboom E.J. Management outcome and follow-up of fetal tachycardia. J. Am. Coll. Cardiol. 1994; 24(5): 1371-5. DOI: 10,1016 / 0735-1097(94)90122-8
- Alsaied T., Baskar S., Fares M., Alahdab F., Czosek R.J., Murad M.H., et al. First-line antiarrhythmic transplacental treatment for fetal tachyarrhythmia: a systematic review and meta-analysis. J. Am. Heart Assoc. 2017; 6(12). pii: e007164.
- Беспалова Е.Д., Суратова О.Г., Бокерия Е.Л., Бартагова М.Н., Гасанова Р.М., Тюменева А.И. Диагностика и лечение кардиальной патологии у плода. Бокерия Л.А., ред. М.: Научный центр сердечно-сосудистой хирургии РАМН, 2015. 244 с.
- Бокерия Е.Л., Беспалова Е.Д., Суратова О.Г. Фетальные органические тахиаритмии: опыт лечения. Анналы аритмологии. 2011; 2: 36-44
- Moise K.J. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am. J. Obstet. Gynecol. 2008; 198(2): 161-4. e1-4. doi: 10.1016 / j.ajog.2007.10.788.
- Weisz B., Rosenbaum O., Chayen B., Peltz R., Feldman B., Lipitz S. Outcome of severely anaemic fetuses treated by intrauterine transfusions. Arch. Dis. Child. Fetal Neonatal Ed. 2009; 94(3): F201-4. doi: 10.1136 / adc.2008.143560.
- Leruez-Ville M, Ghout I., Bussieres L., Stirnemann J., Magny J.F., Couderc S. et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am. J. Obstet. Gynecol. 2016; 215(4): 462. e10. doi: 10.1016 / j.ajog.2016.04.003
- Jacquemard F., Yamamoto M., Costa J.M., Romand S., Jaсqz-Aigrain E., Dejean A. et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG. 2007; 114(9): 1113-21. DOI: 10,1111 / j.1471-0528.2007.01308.x
- Welz J., Muller A, Gembruch U., Geipel A. Intrauterine Therapie der fetalen CMV Infektion mit Valganciclovir, eine Falldarstellung. Geburtshilfe Frauenheilkd. 2016; 76(10): CR004. doi: 10.1055/s-0036-1593310
- Crane J., Mundle Ж, Boucoiran I.; MATERNAL FETAL MEDICINE COMMITTEE. Parvovirus B19 infection in pregnancy. J Obstet. Gynaecol. Can. 2014; 36(12): 1107-16. doi: 10.1016 / S1701-2163 (15) 30390-X.
- Berger V.K., Sparks T.N., Jelin A.C., Derderian C., Jeanty C., Gosnell K. et al. Non-immune hydrops fetalis: do placentomegaly and polyhydramnios matter? J. Ultrasound Med. 2018; 37(5): 1185-91. doi: 10.1016 / S1701-2163 (15) 30390-X.
- Huhta J. C. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr. Cardiol. 2004; 25(3): 274-86. DOI: 10,1007 / s00246-003-0591-3
- Braun T., Brauer M., Fuchs I., Czernik C., Dudenhausen J.W., Henrich W., Sarioglu N. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn. Ther. 2010; 27(4): 191-203. doi: 10.1159 / 000305096
- Gedikbasi A., Oztarhan K., Gunenc Z., Yildirim G., Arslan O., Yildirim D., Ceylan Y. Preeclampsia due to fetal non-immune hydrops: mirror syndrome and review of literature. Hypertens. Pregnancy. 2011; 30(3): 322-30. doi: 10.3109 / 106419509033232